US Patent 11007186 Methods of treating RBP4 related diseases with triazolopyridines
Patent 11007186 was granted and assigned to Belite Bio on May, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 26 Jun, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 15 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 10 Apr, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+242 characters)
Article
Patent abstract
Provided herein are heterocyclic derivative compounds and pharmaceutical compositions comprising said compounds that are useful for the treatment of retinal binding protein (RBP4) related diseases, such as obesity and the like.
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 5 Apr, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110071860
Date of Patent
May 18, 2021
0Patent Application Number
162729110
Date Filed
February 11, 2019
0Official Website
Patent Citations Received
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Patent Citations Received
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110071860
Date of Patent
May 18, 2021
0Patent Application Number
162729110
Date Filed
February 11, 2019
0Official Website
Patent Citations Received
Patent Primary Examiner
Edits on 20 Jul, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 11 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11007186 Methods of treating RBP4 related diseases with triazolopyridines
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11007186
Date of patent
May 18, 2021
Patent application number
16272911
Date Filed
February 11, 2019
Patent primary examiner
Find more entities like US Patent 11007186 Methods of treating RBP4 related diseases with triazolopyridines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
